Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-029206
Filing Date
2025-02-27
Accepted
2025-02-27 17:05:31
Documents
83
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cytk-20241231.htm   iXBRL 10-K 4071889
2 EX-10.21 cytk-ex10_21.htm EX-10.21 43958
3 EX-10.22 cytk-ex10_22.htm EX-10.22 1024642
4 EX-10.33 cytk-ex10_33.htm EX-10.33 44848
5 EX-19.1 cytk-ex19_1.htm EX-19.1 115282
6 EX-23.1 cytk-ex23_1.htm EX-23.1 7963
7 EX-31.1 cytk-ex31_1.htm EX-31.1 17373
8 EX-31.2 cytk-ex31_2.htm EX-31.2 16130
9 EX-32.1 cytk-ex32_1.htm EX-32.1 14725
10 EX-97.1 cytk-ex97_1.htm EX-97.1 55470
11 GRAPHIC img258569631_0.jpg GRAPHIC 374662
  Complete submission text file 0000950170-25-029206.txt   17191247

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cytk-20241231.xsd EX-101.SCH 1980575
86 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20241231_htm.xml XML 2675352
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50633 | Film No.: 25680492
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)